Vytrus Biotech, S.A. (BME:VYT)
Spain · Delayed Price · Currency is EUR 16.50
0.00 (0.00%)
Last updated: Sep 16, 2026, 5:15 PM CET
Vytrus Biotech Market Cap
Vytrus Biotech has a market cap or net worth of €124.02 million as of September 16, 2026. Its market cap has increased by 181.76% in one year.
Market Cap
124.02M
Enterprise Value
121.82M
Revenue
9.69M
Ranking
n/a
PE Ratio
42.82
Stock Price
€16.50
ChartMarket Cap Chart
Since March 15, 2022, Vytrus Biotech's market cap has increased from 15.37M to 124.02M, an increase of 706.98%. That is a compound annual growth rate of 58.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 124.02M | 92.78% |
| Dec 31, 2025 | 64.33M | 294.97% |
| Dec 31, 2024 | 16.29M | 29.02% |
| Dec 29, 2023 | 12.62M | -46.26% |
| Dec 30, 2022 | 23.49M | 52.86% |
| Mar 15, 2022 | 15.37M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Grifols | 5.75B |
| Laboratorios Farmaceuticos Rovi | 2.96B |
| Almirall | 2.30B |
| Faes Farma | 1.41B |
| Clínica Baviera | 907.48M |
| Oryzon Genomics | 229.00M |
| Atrys Health | 222.41M |
| Prim, S.A. | 215.15M |